Digital Chronic Disease Management Market Global Report 2026

The digital chronic disease management market size has grown rapidly in recent years. It will grow from $8.28 billion in 2025 to $9.42 billion in 2026 at a compound annual growth rate (CAGR) of 13.9%. The growth in the historic period can be attributed to rising prevalence of chronic diseases worldwide, increasing healthcare expenditure on long term disease management, growing demand for preventive healthcare services, expansion of telehealth adoption across healthcare systems, increasing focus on reducing hospital admissions and healthcare costs.

The digital chronic disease management market size is expected to see rapid growth in the next few years. It will grow to $15.6 billion in 2030 at a compound annual growth rate (CAGR) of 13.4%. The growth in the forecast period can be attributed to growing demand for continuous patient monitoring solutions, increasing adoption of value based healthcare models, expansion of home healthcare and virtual care services, rising investment in digital health ecosystems, increasing emphasis on patient centric chronic care management. Major trends in the forecast period include increasing adoption of personalized care plans for chronic disease management, growing use of remote patient monitoring programs to reduce hospital readmissions, rising focus on medication adherence tracking and patient engagement solutions, expansion of home based chronic disease management services and virtual care models, increasing integration of multidisciplinary care coordination for long term disease management.

The increasing adoption of telehealth services is expected to propel the growth of the digital chronic disease management market going forward. Telehealth services refer to the delivery of healthcare consultations, monitoring, diagnosis, and patient engagement through digital communication technologies such as video conferencing platforms, remote monitoring systems, and mobile health applications. The increasing adoption of telehealth services is driven by the growing demand for convenient and accessible healthcare, as patients and healthcare providers seek faster remote consultations and continuous care management. Digital chronic disease management supports telehealth services by enabling remote monitoring, continuous patient engagement, personalized treatment support, and real-time management of chronic conditions such as diabetes, hypertension, and cardiovascular diseases. For instance, in April 2023, according to FAIR Health Inc., a US-based nonprofit organization, national telehealth utilization increased by 7.3%, rising from 5.5% of medical claim lines in December 2022 to 5.9% in January 2023. Therefore, the increasing adoption of telehealth services is driving the growth of the digital chronic disease management market.

Leading companies operating in the digital chronic disease management market are focusing on developing innovative products, such as AI-powered care tools, to enhance remote patient monitoring, improve personalized treatment delivery, support continuous patient engagement, and optimize chronic disease outcomes. AI-powered care tools are intelligent digital healthcare solutions designed to analyze patient health data, provide virtual care assistance, deliver personalized therapy recommendations, and support remote chronic disease management. For example, in February 2025, Hinge Health, a US-based digital healthcare company, launched AI-powered care tools, including Movement Analysis and the Robin AI Care Assistant, designed to support musculoskeletal chronic disease management. The platform utilizes computer vision technology and AI-driven virtual assistance to deliver personalized exercise guidance, monitor patient progress remotely, and improve accessibility to digital physical therapy and chronic pain management services.

In February 2025, Teladoc Health Inc., a US-based telemedicine and virtual healthcare company, acquired Catapult Health LLC for $70 million. Through this acquisition, Teladoc Health aimed to strengthen its chronic condition management and preventive care capabilities by integrating at-home diagnostic testing, virtual wellness evaluations, and early disease detection services into its digital healthcare ecosystem. Catapult Health LLC is a US-based digital healthcare company specializing in preventive care, virtual health assessments, chronic disease risk identification, and remote patient engagement solutions.

Major companies operating in the digital chronic disease management market are International Business Machines Corporation; F. Hoffmann-La Roche Ltd.; Bayer Aktiengesellschaft; Koninklijke Philips N.V.; Medtronic plc; AstraZeneca PLC; NTT DATA Group Corporation; Epic Systems Corporation; Teladoc Health Inc.; DexCom Inc.; Abbott Laboratories; Health Catalyst Inc.; AptarGroup Inc.; Hinge Health Inc.; ScienceSoft USA Corporation; Omada Health Inc.; WellDoc Inc.; Virta Health Corp.; Glooko Inc.; DarioHealth Corp.; Credo Health Services Pvt. Ltd.; ResMed Inc.; Biofourmis.

North America was the largest region in the digital chronic disease management market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the digital chronic disease management market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the digital chronic disease management market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The digital chronic disease management market includes revenues earned by entities by providing services such as chronic care coordination, digital therapeutics support, health coaching, patient engagement programs, AI-driven disease monitoring, and data analytics services. The market value includes the value of related goods sold by the service provider or included within the service offering. The digital chronic disease management market also includes sales of continuous glucose monitors, smart blood pressure monitors, pulse oximeters, and connected inhalers. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The digital chronic disease management market research report is one of a series of new reports that provides digital chronic disease management market statistics, including digital chronic disease management industry global market size, regional shares, competitors with a digital chronic disease management market share, detailed digital chronic disease management market segments, market trends and opportunities, and any further data you may need to thrive in the digital chronic disease management industry. This digital chronic disease management market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

This product will be delivered within 1-3 business days.